Injective Protocol (INJ) was trading at $7.91 on September 24, 2026, down 3.66% over the prior 24 hours. The daily decline came as the token gave back a portion of recent gains, though the pullback was modest relative to its broader upward move.
Over the past seven days, INJ has risen 42.14%, reflecting a sustained period of buying pressure that carried the token significantly higher. The 30-day gain stands at 34.73%, indicating that the bulk of the advance occurred within the most recent week of that window.
At current prices, Injective Protocol carries a market capitalization of approximately $0.8 billion. The asset remains in positive territory on both the weekly and monthly timeframes despite the intraday softness.
The daily dip follows a stretch of strong performance that pushed INJ well above where it stood a month ago. Whether the token stabilizes near current levels or continues to consolidate will be reflected in coming sessions.
